Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary Shmeeda

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 22, 2011
Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapyAlberto Gabizon, Hilary Shmeeda, Tal Grenader
Clinical Pharmacokinetics|May 13, 2003
Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studiesAlberto Gabizon, Hilary Shmeeda, Yechezkel Barenholz
Journal of Liposome Research|September 6, 2006
Pros and cons of the liposome platform in cancer drug targetingAlberto A Gabizon, Hilary Shmeeda, Samuel Zalipsky
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 1, 2009
Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passageHilary Shmeeda, Dina Tzemach, Lidia Mak, et al.
Advanced Drug Delivery Reviews|April 20, 2004
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugatesAlberto Gabizon, Hilary Shmeeda, Aviva T Horowitz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 20, 2013
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicityHilary Shmeeda, Yasmine Amitay, Dina Tzemach, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 26, 2016
Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicityYogita Patil, Yasmine Amitay, Patricia Ohana, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 18, 2002
Heat acclimation in rats: modulation via lipid polyunsaturationHilary Shmeeda, Pavel Kaspler, Judith Shleyer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2011
Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor modelsAlberto Gabizon, Yasmine Amitay, Dina Tzemach, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 23, 2018
Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA)Yogita Patil, Hilary Shmeeda, Yasmine Amitay, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 22, 2011
Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapyAlberto Gabizon, Hilary Shmeeda, Tal Grenader
Clinical Pharmacokinetics|May 13, 2003
Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studiesAlberto Gabizon, Hilary Shmeeda, Yechezkel Barenholz
Journal of Liposome Research|September 6, 2006
Pros and cons of the liposome platform in cancer drug targetingAlberto A Gabizon, Hilary Shmeeda, Samuel Zalipsky
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 1, 2009
Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passageHilary Shmeeda, Dina Tzemach, Lidia Mak, et al.
Advanced Drug Delivery Reviews|April 20, 2004
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugatesAlberto Gabizon, Hilary Shmeeda, Aviva T Horowitz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 20, 2013
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicityHilary Shmeeda, Yasmine Amitay, Dina Tzemach, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 26, 2016
Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicityYogita Patil, Yasmine Amitay, Patricia Ohana, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 18, 2002
Heat acclimation in rats: modulation via lipid polyunsaturationHilary Shmeeda, Pavel Kaspler, Judith Shleyer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2011
Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor modelsAlberto Gabizon, Yasmine Amitay, Dina Tzemach, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 23, 2018
Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA)Yogita Patil, Hilary Shmeeda, Yasmine Amitay, et al.
Pageof 4